These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8138960

  • 21. Inhibition of calcimycin-induced stimulation of cytosolic calcium in human PMN by a LTB4 receptor antagonist.
    Heckenberger R, Schrör K.
    Eicosanoids; 1992; 5 Suppl():S23-5. PubMed ID: 1333252
    [Abstract] [Full Text] [Related]

  • 22. Leukotriene B4-activated human endothelial cells promote transendothelial neutrophil migration.
    Nohgawa M, Sasada M, Maeda A, Asagoe K, Harakawa N, Takano K, Yamamoto K, Okuma M.
    J Leukoc Biol; 1997 Aug; 62(2):203-9. PubMed ID: 9261334
    [Abstract] [Full Text] [Related]

  • 23. Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response.
    Goldman DW, Goetzl EJ.
    J Exp Med; 1984 Apr 01; 159(4):1027-41. PubMed ID: 6323613
    [Abstract] [Full Text] [Related]

  • 24. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
    Griffiths RJ, Pettipher ER, Koch K, Farrell CA, Breslow R, Conklyn MJ, Smith MA, Hackman BC, Wimberly DJ, Milici AJ.
    Proc Natl Acad Sci U S A; 1995 Jan 17; 92(2):517-21. PubMed ID: 7831322
    [Abstract] [Full Text] [Related]

  • 25. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
    Showell HJ, Conklyn MJ, Alpert R, Hingorani GP, Wright KF, Smith MA, Stam E, Salter ED, Scampoli DN, Meltzer S, Reiter LA, Koch K, Piscopio AD, Cortina SR, Lopez-Anaya A, Pettipher ER, Milici AJ, Griffiths RJ.
    J Pharmacol Exp Ther; 1998 Jun 17; 285(3):946-54. PubMed ID: 9618393
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. 15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
    Ternowitz T, Fogh K, Kragballe K.
    Skin Pharmacol; 1988 Jun 17; 1(2):93-9. PubMed ID: 2856182
    [Abstract] [Full Text] [Related]

  • 29. Recognition of human polymorphonuclear leukocyte receptors for leukotriene B4 by rabbit anti-idiotypic antibodies to a mouse monoclonal antileukotriene B4.
    Gifford LA, Chernov-Rogan T, Harvey JP, Koo CH, Goldman DW, Goetzl EJ.
    J Immunol; 1987 Feb 15; 138(4):1184-9. PubMed ID: 3027172
    [Abstract] [Full Text] [Related]

  • 30. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R, Elfman F, Perez HD.
    J Immunol; 1989 Sep 15; 143(6):1969-73. PubMed ID: 2550548
    [Abstract] [Full Text] [Related]

  • 31. Photoaffinity labelling and radiation inactivation of the leukotriene B4 receptor in human myeloid cells.
    Slipetz DM, Scoggan KA, Nicholson DW, Metters KM.
    Eur J Pharmacol; 1993 Jan 15; 244(2):161-73. PubMed ID: 8381743
    [Abstract] [Full Text] [Related]

  • 32. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
    Kishikawa K, Tateishi N, Maruyama T, Seo R, Toda M, Miyamoto T.
    Prostaglandins; 1992 Oct 15; 44(4):261-75. PubMed ID: 1332129
    [Abstract] [Full Text] [Related]

  • 33. Second-generation leukotriene B4 receptor antagonists related to SC-41930: heterocyclic replacement of the methyl ketone pharmacophore.
    Penning TD, Djuric SW, Miyashiro JM, Yu S, Snyder JP, Spangler D, Anglin CP, Fretland DJ, Kachur JF, Keith RH.
    J Med Chem; 1995 Mar 17; 38(6):858-68. PubMed ID: 7699700
    [Abstract] [Full Text] [Related]

  • 34. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
    Senior RM, Skogen WF, Griffin GL, Wilner GD.
    J Clin Invest; 1986 Mar 17; 77(3):1014-9. PubMed ID: 3005361
    [Abstract] [Full Text] [Related]

  • 35. New serine protease inhibitors with leukotriene B4 (LTB4) receptor binding affinity.
    Nakayama Y, Senokuchi K, Sakaki K, Kato M, Maruyama T, Miyazaki T, Ito H, Nakai H, Kawamura M.
    Bioorg Med Chem; 1997 May 17; 5(5):971-85. PubMed ID: 9208106
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.
    Jackson WT, Boyd RJ, Froelich LL, Gapinski DM, Mallett BE, Sawyer JS.
    J Med Chem; 1993 Jun 11; 36(12):1726-34. PubMed ID: 8389876
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes.
    Kreisle RA, Parker CW.
    J Exp Med; 1983 Feb 01; 157(2):628-41. PubMed ID: 6296265
    [Abstract] [Full Text] [Related]

  • 40. Leukotriene formation by human polymorphonuclear leukocytes from endogenous arachidonate. Physiological triggers and modulation by prostanoids.
    Haurand M, Flohé L.
    Biochem Pharmacol; 1989 Jul 01; 38(13):2129-37. PubMed ID: 2735951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.